Estrogen receptor-α mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice

Baojian Xue, Jaya Pamidimukkala, Dennis B. Lubahn, Meredith Hay

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

It has been shown that the female sex hormones have a protective role in the development of angiotensin II (ANG II)-induced hypertension. The present study tested the hypotheses that 1) the estrogen receptor-α (ERα) is involved in the protective effects of estrogen against ANG II-induced hypertension and 2) central ERs are involved. Blood pressure (BP) was measured in female mice with the use of telemetry implants. ANG II (800 ng·kg -1·min-1) was administered subcutaneously via an osmotic pump. Baseline BP in the intact, ovariectomized (OVX) wild-type (WT) and ERα knockout (ERαKO) mice was similar; however, the increase in BP induced by ANG II was greater in OVX WT (23.0 ± 1.0 mmHg) and ERαKO mice (23.8 ± 2.5 mmHg) than in intact WT mice (10.1 ± 4.5 mmHg). In OVX WT mice, central infusion of 17β-estradiol (E2; 30 μg·kg-1·day-1) attenuated the pressor effect of ANG II (7.0 ± 0.4 mmHg), and this protective effect of E 2 was prevented by coadministration of ICI-182,780 (ICI; 1.5 μg·kg-1·day-1, 18.8 ± 1.5 mmHg), a nonselective ER antagonist. Furthermore, central, but not peripheral, infusions of ICI augmented the pressor effects of ANG II in intact WT mice (17.8 ± 4.2 mmHg). In contrast, the pressor effect of ANG II was unchanged in either central E2-treated OVX ERαKO mice (19.0 ± 1.1 mmHg) or central ICI-treated intact ERαKO mice (19.6 ± 1.6 mmHg). Lastly, ganglionic blockade on day 7 after ANG II infusions resulted in a greater reduction in BP in OVX WT, central ER antagonist-treated intact WT, central E2 + ICI-treated OVX WT, ERαKO, and central E2- or ICI-treated ERαKO mice compared with that in intact WT mice given just ANG II. Together, these data indicate that ERα, especially central expression of the ER, mediates the protective effects of estrogen against ANG II-induced hypertension.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume292
Issue number4
DOIs
StatePublished - Apr 2007
Externally publishedYes

Fingerprint

Angiotensin II
Estrogen Receptors
Estrogens
Hypertension
Knockout Mice
Blood Pressure
Telemetry
Gonadal Steroid Hormones
Estradiol

Keywords

  • Cardiovascular disease
  • Sex hormone

ASJC Scopus subject areas

  • Physiology

Cite this

Estrogen receptor-α mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice. / Xue, Baojian; Pamidimukkala, Jaya; Lubahn, Dennis B.; Hay, Meredith.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 292, No. 4, 04.2007.

Research output: Contribution to journalArticle

@article{0a3f9ad9fbc74864b97f672bd8bd42c3,
title = "Estrogen receptor-α mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice",
abstract = "It has been shown that the female sex hormones have a protective role in the development of angiotensin II (ANG II)-induced hypertension. The present study tested the hypotheses that 1) the estrogen receptor-α (ERα) is involved in the protective effects of estrogen against ANG II-induced hypertension and 2) central ERs are involved. Blood pressure (BP) was measured in female mice with the use of telemetry implants. ANG II (800 ng·kg -1·min-1) was administered subcutaneously via an osmotic pump. Baseline BP in the intact, ovariectomized (OVX) wild-type (WT) and ERα knockout (ERαKO) mice was similar; however, the increase in BP induced by ANG II was greater in OVX WT (23.0 ± 1.0 mmHg) and ERαKO mice (23.8 ± 2.5 mmHg) than in intact WT mice (10.1 ± 4.5 mmHg). In OVX WT mice, central infusion of 17β-estradiol (E2; 30 μg·kg-1·day-1) attenuated the pressor effect of ANG II (7.0 ± 0.4 mmHg), and this protective effect of E 2 was prevented by coadministration of ICI-182,780 (ICI; 1.5 μg·kg-1·day-1, 18.8 ± 1.5 mmHg), a nonselective ER antagonist. Furthermore, central, but not peripheral, infusions of ICI augmented the pressor effects of ANG II in intact WT mice (17.8 ± 4.2 mmHg). In contrast, the pressor effect of ANG II was unchanged in either central E2-treated OVX ERαKO mice (19.0 ± 1.1 mmHg) or central ICI-treated intact ERαKO mice (19.6 ± 1.6 mmHg). Lastly, ganglionic blockade on day 7 after ANG II infusions resulted in a greater reduction in BP in OVX WT, central ER antagonist-treated intact WT, central E2 + ICI-treated OVX WT, ERαKO, and central E2- or ICI-treated ERαKO mice compared with that in intact WT mice given just ANG II. Together, these data indicate that ERα, especially central expression of the ER, mediates the protective effects of estrogen against ANG II-induced hypertension.",
keywords = "Cardiovascular disease, Sex hormone",
author = "Baojian Xue and Jaya Pamidimukkala and Lubahn, {Dennis B.} and Meredith Hay",
year = "2007",
month = "4",
doi = "10.1152/ajpheart.01011.2005",
language = "English (US)",
volume = "292",
journal = "American Journal of Physiology",
issn = "0363-6143",
publisher = "American Physiological Society",
number = "4",

}

TY - JOUR

T1 - Estrogen receptor-α mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice

AU - Xue, Baojian

AU - Pamidimukkala, Jaya

AU - Lubahn, Dennis B.

AU - Hay, Meredith

PY - 2007/4

Y1 - 2007/4

N2 - It has been shown that the female sex hormones have a protective role in the development of angiotensin II (ANG II)-induced hypertension. The present study tested the hypotheses that 1) the estrogen receptor-α (ERα) is involved in the protective effects of estrogen against ANG II-induced hypertension and 2) central ERs are involved. Blood pressure (BP) was measured in female mice with the use of telemetry implants. ANG II (800 ng·kg -1·min-1) was administered subcutaneously via an osmotic pump. Baseline BP in the intact, ovariectomized (OVX) wild-type (WT) and ERα knockout (ERαKO) mice was similar; however, the increase in BP induced by ANG II was greater in OVX WT (23.0 ± 1.0 mmHg) and ERαKO mice (23.8 ± 2.5 mmHg) than in intact WT mice (10.1 ± 4.5 mmHg). In OVX WT mice, central infusion of 17β-estradiol (E2; 30 μg·kg-1·day-1) attenuated the pressor effect of ANG II (7.0 ± 0.4 mmHg), and this protective effect of E 2 was prevented by coadministration of ICI-182,780 (ICI; 1.5 μg·kg-1·day-1, 18.8 ± 1.5 mmHg), a nonselective ER antagonist. Furthermore, central, but not peripheral, infusions of ICI augmented the pressor effects of ANG II in intact WT mice (17.8 ± 4.2 mmHg). In contrast, the pressor effect of ANG II was unchanged in either central E2-treated OVX ERαKO mice (19.0 ± 1.1 mmHg) or central ICI-treated intact ERαKO mice (19.6 ± 1.6 mmHg). Lastly, ganglionic blockade on day 7 after ANG II infusions resulted in a greater reduction in BP in OVX WT, central ER antagonist-treated intact WT, central E2 + ICI-treated OVX WT, ERαKO, and central E2- or ICI-treated ERαKO mice compared with that in intact WT mice given just ANG II. Together, these data indicate that ERα, especially central expression of the ER, mediates the protective effects of estrogen against ANG II-induced hypertension.

AB - It has been shown that the female sex hormones have a protective role in the development of angiotensin II (ANG II)-induced hypertension. The present study tested the hypotheses that 1) the estrogen receptor-α (ERα) is involved in the protective effects of estrogen against ANG II-induced hypertension and 2) central ERs are involved. Blood pressure (BP) was measured in female mice with the use of telemetry implants. ANG II (800 ng·kg -1·min-1) was administered subcutaneously via an osmotic pump. Baseline BP in the intact, ovariectomized (OVX) wild-type (WT) and ERα knockout (ERαKO) mice was similar; however, the increase in BP induced by ANG II was greater in OVX WT (23.0 ± 1.0 mmHg) and ERαKO mice (23.8 ± 2.5 mmHg) than in intact WT mice (10.1 ± 4.5 mmHg). In OVX WT mice, central infusion of 17β-estradiol (E2; 30 μg·kg-1·day-1) attenuated the pressor effect of ANG II (7.0 ± 0.4 mmHg), and this protective effect of E 2 was prevented by coadministration of ICI-182,780 (ICI; 1.5 μg·kg-1·day-1, 18.8 ± 1.5 mmHg), a nonselective ER antagonist. Furthermore, central, but not peripheral, infusions of ICI augmented the pressor effects of ANG II in intact WT mice (17.8 ± 4.2 mmHg). In contrast, the pressor effect of ANG II was unchanged in either central E2-treated OVX ERαKO mice (19.0 ± 1.1 mmHg) or central ICI-treated intact ERαKO mice (19.6 ± 1.6 mmHg). Lastly, ganglionic blockade on day 7 after ANG II infusions resulted in a greater reduction in BP in OVX WT, central ER antagonist-treated intact WT, central E2 + ICI-treated OVX WT, ERαKO, and central E2- or ICI-treated ERαKO mice compared with that in intact WT mice given just ANG II. Together, these data indicate that ERα, especially central expression of the ER, mediates the protective effects of estrogen against ANG II-induced hypertension.

KW - Cardiovascular disease

KW - Sex hormone

UR - http://www.scopus.com/inward/record.url?scp=34147169312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34147169312&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.01011.2005

DO - 10.1152/ajpheart.01011.2005

M3 - Article

VL - 292

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6143

IS - 4

ER -